Abstract
Normothermic regional perfusion (NRP) is a surgical technique that can improve the quality and number of organs recovered for donation after the determination of death by circulatory criteria. Despite its promise, adoption of NRP has been hindered because of unresolved ethical issues. To inform stakeholders, this scoping review provides an impartial overview of the major ethical controversies surrounding NRP. We undertook this review according to a modified 5-step methodology proposed by Arksey and O’Malley. Publications were retrieved through MEDLINE and Embase. Gray literature was sourced from Canadian organ donation organizations, English-language organ donation organization websites, and through our research networks. Three reviewers independently screened all documents for inclusion, extracted data, and participated in content analysis. Disagreements were resolved through consensus meetings. Seventy-one documents substantively engaging with ethical issues in NRP were included for full-text analysis. We identified 6 major themes encompassing a range of overlapping ethical debates: (1) the compatibility of NRP with the dead donor rule, the injunction that organ recovery cannot cause death, (2) the risk of donor harm posed by NRP, (3) uncertainties regarding consent requirements for NRP, (4) risks to stakeholder trust posed by NRP, (5) the implications of NRP for justice, and (6) NRP’s potential to benefits of NRP for stakeholders. We found no agreement on the ethical permissibility of NRP. However, some debates may be resolved through additional empirical study. As decision-makers contemplate the adoption of NRP, it is critical to address the ethical issues facing the technique to ensure stakeholder trust in deceased donation and transplantation systems is preserved.
INTRODUCTION
Normothermic regional perfusion (NRP) is a promising surgical technique that can improve the quality and quantity of organs recovered for donation after the determination of death by circulatory criteria (DCDD).1-4 By circulating oxygenated blood to target organs in situ, NRP reverses ischemic damage,5 enables assessment of organ function before recovery,6 and facilitates DCDD heart donation.7,8 NRP is now widely used in Europe9,10 and increasingly used at numerous centers in the United States.11-15 Evidence from observational studies suggests that NRP may be superior to alternative organ recovery techniques with respect to cost-effectiveness,3,6,16,17 transplant outcomes,4,18-20 and organ yield.16,21-23
Despite its promise, many jurisdictions have been reluctant to adopt NRP because of unresolved ethical issues.1,24,25 These issues have the potential to undermine the stakeholder trust on which deceased donation and transplantation systems rely.26 As healthcare providers, policymakers, and other decision-makers internationally contemplate the adoption of NRP at scale, it is critical to identify and address these issues to ensure against unintended harms and preserve stakeholder trust.27
Given the evolving literature, keeping abreast of the range of views on the ethics of NRP is challenging. To inform stakeholders, this scoping review provides an impartial overview of the major ethical controversies surrounding NRP. We conclude that the ethical permissibility of NRP is contingent on the resolution of several outstanding empirical questions and ethical controversies.
The focus of this review is limited to ethical issues in NRP as practiced in controlled DCDD (cDCDD-NRP). Although NRP is used in uncontrolled DCDD in several jurisdictions internationally, these protocols present additional ethical issues addressed elsewhere.28 Furthermore, although we touch on legal considerations as they pertain to ethical arguments, analysis of the legal permissibility of NRP is jurisdiction-specific and beyond the scope of this article.29,30
BACKGROUND
In cDCDD, critically ill or injured patients who do not meet the criteria for death determination by neurologic criteria undergo planned withdrawal of life-sustaining measures and progress to circulatory arrest.31 After cessation of circulation, physicians observe a no-touch period (often 5 min) to confirm the permanence of circulatory arrest, after which death is determined and organs are rapidly recovered for transplant.9,10
Organs from cDCDD experience ischemic damage caused by hypotension, hypoxia, and anoxia sustained during and after the dying process.32 Ischemic damage can render organs unsuitable for transplantation or lead to inferior posttransplant outcomes than those observed in recipients of organs derived from donation after neurologic determination of death.
NRP mitigates ischemic injury by using extracorporeal membrane oxygenation technology to perfuse organs with oxygenated blood after death determination.33 Although abdominal NRP (A-NRP) only perfuses organs in the abdominal cavity, thoracoabdominal NRP (TA-NRP) perfuses organs in both the thoracic and abdominal cavities and can restore spontaneous cardiac function and native circulation.1 After the initiation of NRP, perfusion continues for variable periods3,4,34 until organ procurement is performed in a manner similar to donation after neurologic determination of death.35
Because cDCDD donors may retain some neurologic function before death determination, resumption of brain activity or limited function is theoretically possible during NRP through the return of intracranial blood flow.36 Both forms of cDCDD-NRP therefore involve surgical interventions that aim to prevent intracranial flow through ligation, transection, or occlusion of the major arteries to the brain, isolating circulation to target regions of the body.1 In A-NRP, circulation is blocked at the diaphragm; in TA-NRP, circulation is blocked at the level of the great vessels supplying the brain arising from the aortic arch.
On the basis of retrospective, nonrandomized studies, NRP may improve the quality and quantity of organs recovered compared with alternative organ preservation and reconditioning techniques used in cDCDD, such as static cold storage and ex situ machine perfusion.4,18 Furthermore, TA-NRP can facilitate cardiac donation by reducing ischemic time.7,8
MATERIALS AND METHODS
We undertook this review according to a modified 5-step methodology proposed by Arksey and O’Malley37 and further developed by Levac et al.38 The review protocol was published elsewhere.27
Identifying the Research Question
Our review question was broad in scope, necessitating the iterative development of several subquestions consistent with our overall aim of documenting the extent and nature of perspectives on the ethics of NRP (Table 1).
TABLE 1.
Research questions
| Research question | Subquestions |
|---|---|
| What are the real or perceived ethical issues in the use of NRP in cDCDD? | What normative arguments support these ethical concerns? |
| What conceptual issues or uncertainties underlie these ethical concerns? | |
| What empirical issues or uncertainties underlie these ethical concerns? | |
| How are these ethical concerns addressed or resolved in the literature through normative or conceptual argument? | |
| What empirical research has been proposed to address these ethical concerns? | |
| What policy/pragmatic proposals have been advanced to address ethical concerns? | |
| What ethical issues do stakeholders identify as important? |
cDCDD, controlled organ donation after circulatory determination of death; NRP, normothermic regional perfusion.
Identifying Relevant Literature
A clinical research librarian developed a search strategy with controlled vocabulary using 15 known relevant articles for validation. We applied a common search string across MEDLINE and Embase from inception to June 2023 to identify relevant English-language publications (Supplemental Digital Content 1, SDC, http://links.lww.com/TP/D129). We undertook a hand-search of reference lists from frequently cited publications to identify articles not captured by the search strategy. Gray literature was sourced through searches of English-language organ donation organization websites and consultation with our research network.
Study Selection
Three reviewers (M.B., M.G., and N.M.) screened all titles and abstracts against inclusion and exclusion criteria (Supplemental Digital Content 2, SDC, http://links.lww.com/TP/D129). All potentially relevant articles then underwent full-text review by a minimum of 2 reviewers meeting regularly to achieve consensus on inclusion or exclusion. To maximize the inclusiveness of viewpoints, we retained articles if they included at least 1 substantive argument or position relating to the ethical issues surrounding NRP. We defined “substantive” to mean offering a reason in support of an ethical proposition.
Data Charting
We used AirTable software to chart extracted data. Three reviewers knowledgeable in ethics (N.B.M.), medicine (M.B.), and law (M.G.) participated in data charting. Each article was independently assessed by a minimum of 2 reviewers. Our preliminary data chart was iteratively revised as recurring categories of interest emerged from the first 15 articles, then finalized in a consensus meeting (Supplemental Digital Content 3, SDC, http://links.lww.com/TP/D129). Reviewers met virtually 2 times a week to achieve consensus on the relevance of the information extracted and to discuss emerging themes and patterns.
Data Analysis
Extracted data were classified according to our identified categories of interest, after which we undertook thematic categorization by iteratively folding interrelated categories under overarching themes, with some categories informing multiple themes (Table 2). To ensure disconfirming patterns were not overlooked, reviewers regularly discussed emerging findings with each other and other members of the research team familiar with NRP literature. Consistent with the scoping review methodology, we did not assess article quality.37
TABLE 2.
Categories and themes
| Theme | Categories informing theme |
|---|---|
| Dead donor rule | Death determination |
| Brain activity or function | |
| Prevention of intracranial blood flow | |
| Brain-based definition of death | |
| Donor harm | Brain activity or function |
| Antemortem procedures | |
| Prevention of intracranial blood flow | |
| Consent/authorization | Brain activity or function |
| Antemortem procedures | |
| Prevention of intracranial blood flow | |
| Spontaneous heart function | |
| Stakeholder trust | Spontaneous heart function |
| Other—moral distress | |
| Other—language and transparency | |
| Justice | Effect on marginalized/stigmatized populations |
| Stakeholder trust | |
| Beneficence | Beneficence |
| Informed consent/authorization |
RESULTS
We retrieved 1110 unique articles through database searches. In addition, 7 potentially relevant items of gray literature were identified through our research networks and searches of English-language organ donation organization websites. Four more articles were identified by hand-searching reference lists. We used Covidence software to screen citations. After title and abstract screening, 190 potentially relevant publications underwent full-text review. Seventy-one publications were included for full-text analysis (Figure 1).
FIGURE 1.
PRISMA diagram. DCD, donation after circulatory death; NRP, normothermic regional perfusion; PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses; uDCD, uncontrolled organ donation after circulatory determination of death.
Publication types included consensus or position statements, argument-based normative articles, and commentaries (Table 3). Over time, the number of articles per year substantively engaging with ethical issues in NRP increased from zero in 2005, when A-NRP was first protocolized in the United States,39 to >20 in 2022 (Figure 2). Table S1 (SDC, http://links.lww.com/TP/D129) summarizes the main purpose of the included articles and their stance regarding the ethical permissibility of NRP (Table S1, SDC, http://links.lww.com/TP/D129). Of the areas of debate evident in the literature, the most frequently discussed was the implications NRP for death determination (76%), followed by its compatibility with the dead donor rule (DDR; 60%) and the risks of resuming of brain activity or limited function (55%; Table 4).
TABLE 3.
Article types
| Article types | No. of articles |
|---|---|
| Commentary | 17 |
| Conference report or expert panel | 4 |
| Editorial | 3 |
| Ethics piece (normative) | 10 |
| Empirical study | 2 |
| Gray literature (eg, website/internal policy document/position statement) | 4 |
| Legal analysis | 2 |
| Letters to the Editor | 8 |
| Protocol | 1 |
| Qualitative study | 3 |
| Review (scoping, narrative, systematic) | 17 |
FIGURE 2.
Number of included articles substantively engaging with the ethics of NRP, by year. *Final search was undertaken in June 2023. NRP, normothermic regional perfusion.
TABLE 4.
Mention rate for categories of interest
| Categories of interest | Prevalence of topic in articles |
|---|---|
| Act of surgical ligation/occlusion/transaction | 44% (43.6%) |
| Antemortem procedures | 20% (19.7%) |
| Beneficence | 24% |
| Brain-based definition of death | 24% (23.9%) |
| Dead donor rule | 60.5% |
| Death determination | 76% |
| Effect on marginalized/stigmatized populations | 7% |
| Informed consent/authorization | 42% (42.2%) |
| Risk of brain activity or function (death determination; harm) | 55% (54.9%) |
| Spontaneous heart function | 20% (19.7%) |
| Stakeholder trust | 38% |
| Other | 25% |
Here, we present the major themes we identified in the literature. Because several rebuttals are advanced in response to each critique of NRP, the preponderance of positions in favor of NRP should not be taken as a reflection of our stance regarding the ethical permissibility of NRP.
Dead Donor Rule
The DDR is an ethical injunction stipulating that organ recovery cannot be the cause of death. By protecting donors from harm, the rule upholds stakeholder trust in donation systems.40
After its introduction in the 1990s, cDCDD was subjected to controversy as a result of perceptions that it violated the DDR.41-43 The debate centered around whether for the purposes of clinical practice and organ donation death should be considered irreversible—that is, cannot be reversed under any circumstances—or merely permanent—that is, will not be reversed under these circumstances.44 Despite reasoned dissent from some critics,45 it is now widely accepted that death in conventional cDCDD is justifiably determined based on permanence.46,47
The advent of NRP reignited debates regarding cDCDD and the DDR.24 Recognizing that the debates regarding cDCDD-NRP and the DDR are interwoven, below we sequentially describe 3 strands of argument and counterargument discernible in the literature (Table 5).
TABLE 5.
Arguments regarding the consistency of NRP with the DDR
| Argument that NRP violates DDR | Responses |
|---|---|
| NRP invalidates death determination and resuscitates the patient (particularly in TA-NRP). The DDR is therefore violated | The donor has been declared dead. Therefore, no subsequent action could invalidate the death determination |
| The donor is not resuscitated. Regions of their body are perfused. To resuscitate, one must intend resuscitation. There is no intent to resuscitate in TA-NRP | |
| NRP does not restore the integrative unity of the organism. Therefore, it neither resuscitates the donor nor violates the DDR | |
| Death determination may be invalidated, but this shows that the criteria are themselves flawed. NRP does not restore brain function. Because the permanent cessation of brain function is death, NRP neither resuscitates nor violates the DDR | |
| After the reinstitution of circulation, the donor no longer meets the criteria for circulatory determination of death and brain function is not irreversibly lost. By preventing the resumption of brain activity or function during resuscitation, surgical blockage causes neurologic death | The donor has been declared dead by circulatory criteria. Death cannot subsequently be induced in a dead body |
| The cause of death is not the surgical intervention but the underlying medical condition that led to the decision to withdraw life-sustaining measures | |
| Preventing brain circulation during NRP is analogous to other measures intended to prevent the return of brain activity or function in conventional cDCDD (eg, prohibitions on cyclic ventilation) | |
| Death is the permanent cessation of brain function. The prevention of brain circulation merely maintains what has already occurred | |
| Arguing that death is induced by the prevention of brain circulation is tantamount to an acknowledgment that cDCDD donors are not dead. Supporters of conventional cDCDD criticizing cDCDD-NRP are therefore inconsistent in their reasoning | |
| Even if death is the permanent (rather than irreversible) cessation of brain function, this is only assumed in NRP. Furthermore, resumption of intracranial circulation (and therefore perfusion and function) is possible. This could revive the donor and lead to subsequent violations of the DDR | The assumption that brain function is lost permanently is based on sound physiologic principles. Furthermore, there is no evidence that intracranial blood flow resumes during NRP |
| Acknowledging this is a genuine concern, rigorous studies should be undertaken and standardized neuromonitoring protocols should be developed |
cDCDD, controlled organ donation after circulatory determination of death; DDR, dead donar rule; NRP, normothermic regional perfusion; TA-NRP, thoracoabdominal normothermic regional perfusion.
Resuscitation and Death Determination
By reinstituting circulation after death determination based on the permanent cessation of circulation, NRP seems to upset the cDCDD death determination framework.25 This is particularly problematic in jurisdictions such as the United States and Australia, where legislation implies that the reinstitution of circulation would legally invalidate death determination.1 Whether resumption of circulation has ethical implications for the DDR is widely discussed in the literature.
Critics argue that NRP not only invalidates death determination from a medico-legal perspective,29 but also that the resumption of circulation implies that the donor has been “successfully resuscitated.”48 It follows that subsequent organ recovery violates the DDR. This argument has most traction with respect to TA-NRP, where spontaneous cardiac function can be restored, allowing the donor to be weaned from the extracorporeal circuit.
Proponents of cDCDD-NRP respond to this charge in at least 4 ways. First, because the donor has been declared dead, no subsequent action could invalidate death determination because this would be a contradiction.49 After death determination, argue Parent et al,50 the donor is dead by definition: “a dead donor cannot be ‘made’ dead, nor can organ retrieval cause death in a dead body.” In response, critics suggest that this argument begs the question because it presupposes what is at issue—the physiologic state of the donor.51 As DeCamp et al52 note, “[i]t is no defense to suggest the patient was already dead when the action [recirculation] negates the conditions upon which that determination was made.”
Second, supporters of NRP argue that while on a “rigid and impractical”53 reading, it is plausible to suggest reinstitution of circulation technically invalidates death determination; this ignores the role of intent.50,54 To resuscitate a patient, they argued, one must intend resuscitation. “Resuscitation efforts require attempting to restart the heart for life-saving/prolonging purposes. In undertaking [cDCDD-NRP], there is no intention or attempt to resuscitate…”50 The donor is not alive; rather, regions of their body are perfused for the purposes of donation. Opponents reject this reasoning, implying that it strains semantics. “Even if the stated intent of [cDCDD-NRP] is to preserve the organs (not to resuscitate the patient), this obscures and cannot be separated from what actually happens: NRP does resuscitate the patient.”48
Capitalizing on a well-known definition of death, a third response to the charge that NRP resuscitates the patient and violates the DDR posits that, while TA-NRP restores the function of several vital organs, it does not restore the integrated function of the organism as a whole.55 Indeed, argue Wall et al,56 the donor is restored to life no more than they would be were all vital organs save the brain removed and perfused en bloc: “While it is optically different to see a heart restart in the body rather than on a perfusion device, there is no ethical difference…” Opponents do not find this compelling, holding that TA-NRP—unlike conventional cDCDD—is predicated on (induced) brain death.57
The fourth response to the argument that NRP violates the DDR acknowledges that the traditional criteria for death determination in cDCDD are plausibly invalidated by the resumption of circulation but denies that this says anything about the physiologic state of death of the donor.58-60 With some exceptions,47 clinical guidelines for death determination in cDCDD hold that death is determinable based on the permanent cessation of circulation but do not go further to explain why that is so. Defenders of NRP attempt to do so, arguing that the only reason circulatory criteria were ever valid was because they identify, by extension, the permanent cessation of brain function.2,3,10 As Bernat et al58 argue, “the use of the unified brain-based concept of death resolves the dilemma by clarifying that the relevant circulation that must cease is circulation to the brain.”58 So long as intracranial blood flow has stopped, the brain cannot function, and the donor is deceased; whether circulation continues extracranially is beside the point.61 Critics respond that this redefinition of death is at worst gerrymandering, at best not within the purview of supporters of NRP.52
Prevention of Intracranial Blood Flow
Another prominent strand of argument for why NRP violates the DDR focuses on the surgical act of ligating, transecting, or occluding the major vessels to the brain to prevent intracranial blood flow and ensure the permanent cessation of brain function in TA-NRP.62,63 In April 2021, the American College of Physicians (ACP)48 argued provocatively that, far from being a postmortem procedure, cDCDD-NRP is “more accurately described as organ retrieval after cardiopulmonary arrest and the induction of brain death.” Citing a commonly accepted theory of causation, Courtwright64 elucidates the argument:
c is a cause of e just in case had c not occurred, e would not have occurred and there exists a causal chain leading from c to e. In NRP, the event (e) is the permanent loss of brain function, and the cause (c) is occlusion of the cerebral circulation. If occlusion of the cerebral circulation had not occurred, the donor would not predictably have had permanent loss of brain function.
After the reinstitution of circulation, the donor no longer meets the criteria for circulatory determination of death and brain function is not irreversibly lost in at least some cases. By preventing the resumption of brain activity or limited function during resuscitation, the surgical blockage causes neurologic death—defined in some jurisdictions as the irreversible loss of all brain function—and may render physicians complicit in the donor’s death.65-67
Proponents of NRP respond to this argument in ways that roughly mirror the defenses described above. First, because the death of the donor has been determined, it is implausible to argue that the donor can be made dead a second time over.50 Detractors retort by questioning why, if the donor is truly dead, it is thought necessary to prevent intracranial blood flow in the first place.26,43
Second, highlighting the goals of the donor and healthcare team, defenders of NRP argue that surgical blockage merely ensures that the natural trajectory toward irreversible cessation of brain function is not interrupted:30,50 The cause of death is not the surgical intervention, but the underlying medical condition that led to the decision to withdraw life-sustaining measures.3,10,56 Critics respond that surgical blockage is anything but natural.48,52
Third, supporters point to other measures intended to prevent the resumption of brain function in DCDD, such as prohibitions on cyclic ventilation, and ask whether surgical blockage is really so different.30,59 Leaning on a distinction between “doing” and “allowing,” detractors respond that active intervention is morally different than an omission.25,68
Fourth, given that death is the permanent cessation of brain function, surgical blockage merely maintains what has already occurred.49 Furthermore, the permanent cessation of brain function was the agreed-upon outcome from the start.60 Critics remain unconvinced, arguing that to “maintain” is to “cause” and that the use of misleading language is dishonest.51,65
A final, somewhat indirect response to the charge that surgical blockage is the cause of death highlights alleged inconsistencies in that argument’s reasoning. The ACP contends that the donor is rendered dead by neurologic criteria in part because the donor undergoing NRP no longer meets the criteria for circulatory determination of death.48 As Wall et al30 argue, the statement from the ACP implies there are literally 2 types of death, that one can be dead in one way but not another, and that “one can be declared dead twice in 2 different ways.” An unwelcome consequence, Wall et al30 continue, is that “in framing the act of excluding cerebral circulation as ‘bringing on brain death’ the ACP is implying that circulatory death is not death, which brings the entire practice of DCD donation… into question.” The implication is that we should not put too much stock in the bifurcated character of death determination standards, medico-legal constructs that are meant to identify the same phenomenon—death.
Brain Activity and Function
Another strand of argument regarding the consistency of NRP with the DDR concerns the potential for the resumption of brain activity or limited function through intracranial circulation. Under the unifying brain-based definition of death, death is the permanent cessation of brain function, determined using either circulatory or neurologic criteria.47,58 Because in some cases the cDCDD donor has likely not irreversibly lost all brain function at the time NRP is initiated, “it is essential that all brain circulation has ceased completely and is not restored by NRP or any other means.”58 Otherwise, the donor would no longer meet the definition of death, and organ recovery would violate the DDR.10
Even supporters of NRP raise concerns about the risk of intracranial circulation through the failure of surgical safeguards, collateral vessels, or anatomic variations.69 Because the minimal pressures to sustain neuronal perfusion and function are unknown,70 it is necessary to rely on the complete exclusion of intracranial flow to ensure the permanent cessation of brain function.71 However, in most protocols, this exclusion is only assumed, not monitored for—to the consternation of commentators who argue this should to be an “essential component” of NRP.3,35 Asks Dalle Ave72: “Is society ready to accept such ‘assumability’ of death?”
Recent studies with small sample sizes have found no intracranial blood flow during NRP (where intracranial blood pressure was used as a surrogate for flow).73,74 Further prospective research will help to resolve the debate on the compatibility of NRP with the DDR when considered in relation to the unified, brain-based definition of death.
Donor Harm
Closely related to debates regarding NRP and the DDR are those concerning the potential for both welfare and dignitary harms to donors (some of which overlap). Although these debates are often subsumed under broader discussion of the compatibility of NRP with the DDR, they are important areas of focus for a minority of commentators.75,76
Welfare Harms
As the Organ Procurement and Transplantation Network notes in its analysis of NRP, the technology “raises concerns about the potential for harm if the assumption that the donor is insensate is incorrect following restoration of circulation…”26 Although donors are presumed to have permanently lost all brain function after death determination, sufficient levels of intracranial blood flow could lead to the restoration of brain function, and, consequently, donor sentience.77
The possibility of donor sentience during organ recovery—even if remote—gives stakeholders pause, and even proponents of NRP acknowledge that current protocols have not been shown definitively to exclude all intracranial blood flow.36,69,78 The restoration of donor sentience would violate the ethical principle of nonmaleficence (“do no harm”) and jeopardize stakeholder trust in donation. Although some respond that NRP “has not been found to harm the potential donor patient in any way,”79 the absence of reports of the return of brain activity or function in the literature is not definitive80—indeed, to our knowledge, brain blood flow has been studied in only 4 donors undergoing TA-NRP to date.73,74
Proponents agree that ensuring donor safety is critical to the ethical permissibility of NRP; there is little disagreement on this, even among those who consider the prospect of sentience exceedingly remote. For this reason, many advocate for rigorous study of the effectiveness of surgical safeguards and the implementation of standardized neuromonitoring throughout the procedure. This is especially true of TA-NRP protocols, where the risk of collateral flow to the brain is higher.1,36,58,78
Dignitary Harms
Critics of cDCDD have long argued that the practice causes dignitary harms, alleging that it uses the donor as mere means rather than treating them as an end in themselves, interferes with end-of-life care, and involves premortem interventions (eg, heparin administration) that are not in the donor’s best medical interest.42,76,81 Insofar as conventional cDCDD and cDCDD-NRP protocols consist of the same steps, NRP poses no new ethical issues. However, NRP exacerbates dignitary concerns owing to what some worry are “disturbingly invasive” aspects of the procedure.82,83
NRP protocols involve 2 interventions that detractors argue undermine the dignity of dying and recently deceased patients: premortem cannulation to enable rapid reperfusion (a procedure not permitted in most jurisdictions practicing NRP), and surgical measures to prevent intracranial blood flow. Although noting that the first is not necessary to NRP,30 proponents hold that, provided surrogate consent is obtained, both are respectful of the donor because they pose minimal risk of harm and uphold donor wishes.
Surgical blockage of intracranial blood flow is the more contentious intervention, especially for those who consider it to “bring on death.”48 As the ACP argues, “[t]he ethical obligation to respect persons, including the dying and the dead, limit[s] what can and should be done in organ retrieval.”48 Even some who are tepidly supportive of NRP argue that the maneuver may be “unjustified and contrived only to satisfy the technical requirements for the death determination.”66
In contrast, supporters of NRP hold that ligation, occlusion, or transection is the very opposite of a dignitary harm as it respects the donor’s wish not to be resuscitated and maximizes their chances of successful donation.3,10,49,84 Other defenders take a different approach by analogizing surgical blockage to widely accepted practices in conventional cDCDD: “in principle, [surgical blockage] is no different to all the other precautions taken to prevent restoration of the cerebral circulation during [conventional] DCD organ recovery…” (eg, forbidding cyclical ventilation).59
Consent
The ethical issues described above fuel debates regarding how—or whether—specific informed consent to NRP should be sought. On one end of the spectrum are vocal detractors who argue that, because “consent cannot confer ethical legitimacy”48 on an unethical practice, informed consent to NRP is not sufficient for moral permissibility. On the other end are those who contend that consent may not even be needed, provided NRP surgical safeguards are proven effective, because the procedure could be subsumed under consent to organ donation.85 More frequently, the debate concerns how much information needs to be disclosed to surrogates to enable informed decision-making.85
Although surgical detail regarding conventional cDCDD is not generally disclosed to surrogate decision-makers, some believe NRP is such a departure from usual practice that its use demands disclosure of specific aspects of the procedure.26,65 These include surgical blockage of cerebral vessels, the resumption of circulation, and the restoration of spontaneous cardiac function in TA-NRP.35,48,59 Some go further, suggesting that “a reasonable person would want to know” that while many commentators recommend neurologic monitoring during NRP to ensure donor safety, this is not standard protocol.65 This latter view implies that some believe disclosing empirical uncertainties—and ethical ones—is necessary for valid informed consent as a result of what are perceived to be material risks.
The level of information surrogates need and desire is not known. As Parent et al86 argue, “[i]nformed consent is not just dumping all details on grieving traumatized families.” Yet, what level of detail is too much, and what level is too little? In the absence of qualitative research involving donor families, this is difficult to judge.
Stakeholder Trust
Stakeholder trust is the cornerstone of deceased donation systems.26 There is widespread concern in the literature that perceptions of NRP as an unethical practice could undermine this trust, exacerbating the organ shortfall. Although some speculate that the “potential loss of public trust… might be overstated” given that donation systems are resilient “even in the face of scandals and mistrust,”87 others are not so sanguine. Any adverse event stemming from NRP, argue Shapey et al85 , would have a “catastrophic impact. On the issue of the potential impact of NRP on stakeholder trust, there are 3 prominent areas of dispute.
Language and Transparency
Critics of NRP argue that proponents use misleading language in describing NRP to minimize legitimate ethical concerns.52,65 Far from maintaining death, surgical ligation induces death; rather than perfusing, NRP resuscitates; instead of being dead when NRP is initiated, the donor is dying. This lack of transparency, critics argue, has the potential to undermine trust, as honesty is critical to its preservation. The defenders of NRP reject these characterizations (eg, “NRP perfuses the body of the deceased. It does not resuscitate the patient”).50 Given that one’s characterization of NRP is contingent on underlying commitments regarding the definition of death, it is no surprise that there is disagreement in this area.
Spontaneous Heart Function
Because TA-NRP commonly restores cardiac function, there is some concern in the literature that NRP may exceed the permissible limits of organ recovery for some populations.81,88,89 The issue here, although related to those surrounding the DDR, concerns perceptions rather than the DDR specifically. As Shah notes, “[t]he very notion of death for all recorded time is that your heart has stopped.”90 The resumption of spontaneous heart function in TA-NRP, some fear, “may be perceived by stakeholders as […an] egregious violation of death determination.”36 Although to our knowledge there has been no public outcry in jurisdictions practicing TA-NRP, these fears find some support in survey research that describes “discomfort” regarding NRP among the Canadian public despite general support for the technique,91 although there is otherwise a lack of qualitative research on this issue.92
Although cDCDD was previously known as donation after “cardiac” death, it is now generally agreed that death determination by circulatory criteria is reliant on the observed cessation of circulation, be it bodily or intracranial.93-95 Implicitly relying on a unified, brain-based definition of death, the defenders of NRP argue that provided intracranial circulation is excluded, the restoration of spontaneous cardiac function poses at worst an issue of perception.30,56 That is, although a beating heart may give stakeholders pause, it does not have any ethical significance. An implication is that NRP could be adopted in a trust-preserving way if stakeholder education is appropriately nuanced.
Moral Distress
Moral distress occurs when professional or institutional roles require performing an action that the agent perceives to be morally wrong.96 Anecdotal reports and some survey findings support the contention that healthcare providers are uncertain about the ethical legitimacy of NRP.26 DeJohn and Zwischenberger97 noted that “some members of the medical team are disturbed to see the donor’s heart start beating although death has been declared.” Honarmand et al98 reported that, although overall in favor of TA-NRP, Canadian healthcare providers are less supportive of it than they are of direct procurement and ex situ perfusion, potentially due in part to ethical concerns.
Although there are little international data on healthcare provider perceptions of NRP, debates in the literature suggest that the technique has divided the organ donation and transplantation communities. Healthcare provider buy-in is critical to deceased donation systems, so further research on medical professionals’ views is needed.
Justice
An infrequently addressed theme in the NRP literature stems from a claim by the ACP that the use of NRP could disproportionately affect stigmatized and underserved populations, especially in North American jurisdictions affected by the opioid epidemic.48 According to the ACP, victims of opiate or other drug overdose may be more likely than others to become candidates for cDCDD and, hence, NRP. The ACP asks rhetorically: “Does this fulfill the requirements of justice for an equitable distribution of benefits and burdens within society?”48
Proponents of NRP dismiss this argument, not least because it presupposes that NRP is harmful.30 Acknowledging that the opioid epidemic is indeed of great concern, James et al53 argue that it is separable from the ethical issues in NRP:
The procurement of organs after the declaration of death has no impact on the medical care received by patients antemortem or the cause of their death. Refusing to allow this method of optimizing donation does nothing to subdue the opioid epidemic; instead, it denies donor/surrogate(s) what is perhaps the best opportunity to find purpose and altruism within profound grief.
Beneficence
The above quote points to a final theme in the literature, namely the disputed ethical significance of the acknowledged potential of NRP to advance the goals of beneficence by maximizing benefits to organ recipients, donors, their families, and society.49,50,84,90,99,100
Whatever one thinks of the ethics of NRP, most agree that it is likely an effective intervention that may be more cost-effective than alternative organ recovery protocols.17-23 Proponents note that the technique can contribute to the fulfillment of donors’ altruistic wishes, help families find meaning in loss, improve outcomes for recipients, and increase organ supply for the benefit of waitlisted patients, donation systems, and society. Donation and transplantation communities arguably have a duty to maximize benefits for stakeholders and honor the legacy of donors who have authorized donations.99 Seen in this light, argues Lazaridis, NRP becomes a moral imperative, “not only permissible but ethically required.”101
Although acknowledging that NRP could benefit stakeholders, detractors remain skeptical. Commentators note that medical ethics requires judgment when principles come into conflict. The ends that NRP serves cannot be allowed to mask the ethical impropriety of NRP, some argue, “no matter how noble or good those ends may be.”48
DISCUSSION
NRP raises complex questions regarding the permissible limits of organ recovery techniques, clinical practices for death determination, stewardship of donation systems, theories of causation, and the definition of death. Our scoping review of the medical and bioethical literature found that controversies around NRP are characterized by a polarity of viewpoints driven by underlying commitments regarding these issues.
Despite divided opinions on the ethics of NRP, there is agreement in the literature that at least 3 debates may be resolved through additional empirical study.25 First, both proponents and critics agree that further research with rigorous neuromonitoring is needed to confirm that surgical safeguards are effective in preventing intracranial blood flow during NRP. The need to develop protocolized neuromonitoring for NRP is also a widely endorsed proposal among commentators. Second, there is limited qualitative research to inform what surrogate decision-makers need and want to know in the context of consent discussions. This dialogue would benefit from further consultation with stakeholders.2 Third, the debate on the potential impact of the implementation of NRP on stakeholder trust could be informed by further qualitative research involving healthcare providers and the public. That NRP is widely used in Europe and has not resulted in scandal or public outcry is reassuring but not definitive. Several other research and policy initiatives are also widely advocated in the literature, although support for these is not unanimous (Table 6).
TABLE 6.
Commonly advocated research initiatives relating to ethical issues in NRP
| Research area | Specific recommendations for research |
|---|---|
| Donor safety and surgical safeguards | Determine the effectiveness of surgical safeguards through protocolized neuromonitoring in the research context |
| Determine optimal surgical safeguards in A-NRP and TA-NRP | |
| Develop protocolized neuromonitoring for NRP, for use in clinical practice settings | |
| Determine minimal pulse pressures to sustain brain perfusion, activity, and function | |
| Stakeholder engagement | Qualitative research with healthcare providers and the public to determine stakeholder perspectives on acceptability and its potential impact of NRP on trust in donation |
| Qualitative research with donor families and the public to inform the development of optimal consent processes and informational needs | |
| Engage stakeholders in policy and practice development and provide public education. | |
| Conceptual and policy initiatives | Adopt a unified, brain-based definition of death and clarify the physiologic rationale for death determination by circulatory criteria |
| Harmonize death definition and determination practices internationally | |
| Standardize NRP protocols |
A-NRP, abdominal NRP; NRP, normothermic regional perfusion; TA-NRP, thoracoabdominal NRP.
Unfortunately, not all debates are amenable to empirical resolution. For example, some arguments relating to the DDR ultimately rely on views of death and causation that are inherently debatable. That proponents contend there is no ethical dilemma posed by NRP,1 whereas others say it amounts to killing,48 is illustrative of the polarity of views on this issue. Although some capitalize on the contentious conceptual implications of NRP for death determination to argue for a relaxation of the DDR,43 this proposal does not seem to be widely supported in the donation and transplantation communities, meaning achieving consensus on the compatibility NRP with the DDR will be critical for the future development of NRP.
In the interest of advancing this latter debate, it is worth noting that we observed controversy regarding the DDR sometimes suffers from a commingling of ethical and legal arguments. For example, even if NRP is incompatible with the United States Uniform Determination of Death Act because of the reinstitution of circulation, it does not necessarily follow that subsequent organ recovery violates the DDR. This is because the bifurcated standard for death determination enshrined in the act may be a shortcoming that does not reflect the physiologic reality of death in all contexts. Distinguishing between ethical and legal categories of argument would help to clarify the parameters of this debate, especially for stakeholders outside the United States.75 There is a growing group of commentators arguing that if NRP is to be considered compatible with the DDR from an ethical perspective, a unified, brain-based definition of death based on the permanence principle will need to be accepted. If so, ethical and empirical arguments may have implications for law, but the converse does not hold.
We observed that concern for donor welfare is sometimes subsumed under a broader discussion of adherence of NRP to the DDR. Because concern for donor welfare extends beyond adherence to the DDR, this potentially distracts from the rule’s foundations to some extent. Furthermore, a focus on the DDR—while critical to any ethical analysis of NRP—may be divorced from the concerns of stakeholders such as donor families focused on the well-being of the patient who is a candidate for cDCDD. Here again, further consultation with stakeholders is needed.
Even if a practice is supported by 1 ethical principle, this does not mean it is ethical; it must also meet the demands of others.26 Any conflicts between these principles should be resolved to the satisfaction of stakeholders. Although NRP serves to uphold demands of beneficence, it should also meet those of justice, utility, and respect for persons. Whether it does is a matter of judgment that will be informed by further debate, but it is worth noting that perspectives on this question will always be contingent on one’s positions on prior questions, such as the compatibility of NRP with the DDR. To advance dialogue and focus debate, Table 7 lists outstanding ethical questions that we judge are not resolvable by empirical research alone.
TABLE 7.
Ethical questions facing NRP not resolvable solely by empirical means
| Area of ethical debate | Focused question |
|---|---|
| Dead donor rule | What is the definition of death that should govern clinical practice and deceased donation? |
| Does invalidation of traditional criteria for circulatory death determination have ethical implications? | |
| Is TA-NRP a form of interrupted resuscitation? | |
| Does the resumption of spontaneous cardiac function and native circulation in TA-NRP have ethical implications? | |
| Does NRP induce brain death? | |
| Is surgical blockage of intracranial blood flow an ethically significant intervention? | |
| Donor harm | To what extent should donor “best interests” encompass nonmedical interests? |
| Is NRP consistent with respect for persons and the dignity afforded to human bodies? | |
| Consent | What consent processes are needed to satisfy the demands of respect for autonomy and patient-and-family-centered care? |
| Can consent to NRP be subsumed under consent for organ donation? | |
| What level of detail regarding NRP should be communicated to surrogate decision-makers? | |
| Stakeholder trust | Is NPR consistent with the societally acceptable limits of organ recovery practices? |
| How should moral distress or conscientious objection to NRP among healthcare providers be managed? | |
| Who should be responsible for deciding on the adoption or nonadoption of NRP, and how should this decision be made? | |
| Justice | Is NRP consistent with the principle of justice? |
| How should the benefits and burdens of NRP be distributed equitably? | |
| Beneficence | What weight should be given to the benefits of NRP when assessing its ethical permissibility? |
| Is NRP adoption a moral imperative given its potential to benefit stakeholders? |
NRP, normothermic regional perfusion; TA-NRP, thoracoabdominal NRP.
Encouragingly, the divergence of viewpoints on NRP is reminiscent of earlier debates on the ethical permissibility of conventional cDCDD, debates that have been resolved to the satisfaction of most in the donation and transplantation communities. This suggests that consensus on whether or how to proceed with further expansion of NRP may be achieved through ongoing, iterative argument and discussion.
Limitations
This review benefited from a robust methodological approach including 3 reviewers knowledgeable in ethics, medicine, and law and an authorship group with content expertise in bioethics, critical care, donation science, law, transplantation, and perfusion technologies. However, for feasibility reasons, we included only English-language literature. As NRP (particularly A-NRP) is widely practiced in Europe, this is a limitation of the review. Furthermore, consistent with the scoping review methodology, we did not assess article quality, meaning publications of low quality may have been included. Finally, because we excluded articles that discussed only NRP in uncontrolled DCDD, we may not have captured all arguments relevant to cDCDD-NRP as the 2 applications of extracorporeal membrane oxygenation have commonalities.
CONCLUSIONS
This scoping review provides an overview of the major ethical arguments and controversies surrounding cDCDD-NRP. We found no consensus in the literature on the ethical permissibility of the practice. As healthcare providers, policymakers, and other decision-makers internationally contemplate the adoption of NRP, it is critical that they address the issues described earlier to ensure stakeholder trust in deceased donation and transplantation systems is preserved. We recommend the continuation of open and constructive dialogue and further empirical research to determine the ethical permissibility of NRP.
ACKNOWLEDGMENTS
The authors thank Alla Iansevitchene, clinical research librarian, for her invaluable assistance in developing and implementing the literature search strategy.
Footnotes
This research was funded by a Canadian Donation and Transplantation Research Program Research Innovation Grant, jointly supported by Ontario Health—Trillium Gift of Life Network and the Canadian Donation and Transplantation Research Program.
J.A.G. holds a New Frontiers in Research Fund Transformation Grant to pursue clinical and research opportunities presented by ex vivo organ perfusion platforms. C.W. receives consulting income from Cardialen, Eli Lilly & Company, and Research Triangle Institute International. M.S. receives a stipend for his work as the Regional Medical Lead (Donation) with Ontario Health—Trillium Gift of Life Network. He also holds peer-reviewed research grants from the New Frontiers in Research Fund and the Canadian Institute of Health Research to study neurologic function during the dying process to inform deceased donation practices. A.H. receives a stipend for his work as the Provincial Medical Director, Organ and Tissue Donation with Ontario Health—Trillium Gift of Life Network. The other authors declare no conflicts of interest.
N.B.M. and C.W. conceived the project. N.B.M. authored the first and all subsequent versions of the article. M.B., M.G., and N.B.M. participated in article screening and selection, data extraction, and analysis. J.B., L.B., M.B., M.B., J.A.C., S.D., M.G., J.A.G., A.H., L.L., M.O., S.D.S., M.S., and C.W. participated in writing the article and revised it for important intellectual content. All authors approved the final version of the article.
Supplemental digital content (SDC) is available for this article. Direct URL citations appear in the printed text, and links to the digital files are provided in the HTML text of this article on the journal’s Web site (www.transplantjournal.com).
REFERENCES
- 1.Manara A, Shemie SD, Large S, et al. Maintaining the permanence principle for death during in situ normothermic regional perfusion for donation after circulatory death organ recovery: a United Kingdom and Canadian proposal. Am J Transplant. 2020;20:2017–2025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Shemie SD, Torrance S, Wilson L, et al. Heart donation and transplantation after circulatory determination of death: expert guidance from a Canadian consensus building process. Can J Anaesth. 2021;68:661–671. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Miñambres E, Royo-Villanova M, Domínguez-Gil B. Normothermic regional perfusion provides a great opportunity to maximize organ procurement in donation after the circulatory determination of death. Crit Care Med. 2022;50:1649–1653. [DOI] [PubMed] [Google Scholar]
- 4.Hessheimer AJ, de la Rosa G, Gastaca M, et al. Abdominal normothermic regional perfusion in controlled donation after circulatory determination of death liver transplantation: outcomes and risk factors for graft loss. Am J Transplant. 2022;22:1169–1181. [DOI] [PubMed] [Google Scholar]
- 5.Watson CJE, Hunt F, Messer S, et al. In situ normothermic perfusion of livers in controlled circulatory death donation may prevent ischemic cholangiopathy and improve graft survival. Am J Transplant. 2019;19:1745–1758. [DOI] [PubMed] [Google Scholar]
- 6.Alamouti-Fard E, Garg P, Wadiwala IJ, et al. Normothermic regional perfusion is an emerging cost-effective alternative in donation after circulatory death (DCD) in heart transplantation. Cureus. 2022;14:e26437. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Messer S, Cernic S, Page A, et al. A 5-year single-center early experience of heart transplantation from donation after circulatory-determined death donors. J Heart Lung Transplant. 2020;39:1463–1475. [DOI] [PubMed] [Google Scholar]
- 8.Miñambres E, Royo-Villanova M, Pérez-Redondo M, et al. Spanish experience with heart transplants from controlled donation after the circulatory determination of death using thoraco-abdominal normothermic regional perfusion and cold storage. Am J Transplant. 2021;21:1597–1602. [DOI] [PubMed] [Google Scholar]
- 9.Lomero M, Gardiner D, Coll E, et al. ; European Committee on Organ Transplantation of the Council of Europe (CD-P-TO). Donation after circulatory death today: an updated overview of the European landscape. Transpl Int. 2020;33:76–88. [DOI] [PubMed] [Google Scholar]
- 10.Domínguez-Gil B, Ascher N, Capron AM, et al. Expanding controlled donation after the circulatory determination of death: statement from an international collaborative. Intensive Care Med. 2021;47:265–281. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Bommareddi S, Lima B, Shah AS, et al. Thoraco-abdominal normothermic regional perfusion for thoracic transplantation in the United States: current state and future directions. Curr Opin Organ Transplant. 2024;29:180–185. [DOI] [PubMed] [Google Scholar]
- 12.Kwon JH, Usry B, Hashmi ZA, et al. Donor utilization in heart transplant with donation after circulatory death in the United States. Am J Transplant. 2024;24:70–78. [DOI] [PubMed] [Google Scholar]
- 13.Zhou AL, Leng A, Ruck JM, et al. Kidney donation after circulatory death using thoracoabdominal normothermic regional perfusion: the largest report of the United States experience. Transplantation. 2024;108:516–523. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Croome KP, Brown TE, Mabrey RL, et al. Development of a portable abdominal normothermic regional perfusion (A-NRP) program in the United States. Liver Transpl. 2023;29:1282–1291. [DOI] [PubMed] [Google Scholar]
- 15.Wall A, Gupta A, Testa G. Abdominal normothermic regional perfusion in the United States: current state and future directions. Curr Opin Organ Transplant. 2024;29:175–179. [DOI] [PubMed] [Google Scholar]
- 16.Bakhtiyar SS, Maksimuk TE, Gutowski J, et al. Association of procurement technique with organ yield and cost following donation after circulatory death. Am J Transplant. 2024;24:1803–1815. [DOI] [PubMed] [Google Scholar]
- 17.Boteon YL, Hessheimer AJ, Brüggenwirth IMA, et al. The economic impact of machine perfusion technology in liver transplantation. Artif Organs. 2022;46:191–200. [DOI] [PubMed] [Google Scholar]
- 18.Merani S, Urban M, Westphal SG, et al. Improved early post-transplant outcomes and organ use in kidney transplant using normothermic regional perfusion for donation after circulatory death: national experience in the US. J Am Coll Surg. 2024;238:107–118. [DOI] [PubMed] [Google Scholar]
- 19.Fiedler AG, DeVries S, Czekajlo C, et al. Normothermic regional perfusion surgical technique for the procurement of cardiac donors after circulatory death. JTCVS Tech. 2022;12:113–115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Watson CJE, Hunt F, Messer S, et al. In situ normothermic perfusion of livers in controlled circulatory death donation may prevent ischemic cholangiopathy and improve graft survival. Am J Transplant. 2019;19:1745–1758. [DOI] [PubMed] [Google Scholar]
- 21.Oniscu GC, Mehew J, Butler AJ, et al. Improved organ utilization and better transplant outcomes with in situ normothermic regional perfusion in controlled donation after circulatory death. Transplantation. 2023;107:438–448. [DOI] [PubMed] [Google Scholar]
- 22.Bekki Y, Croome KP, Myers B, et al. Normothermic regional perfusion can improve both utilization and outcomes in DCD liver, kidney, and pancreas transplantation. Transplant Direct. 2023;9:e1450. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Thomas J, Chen Q, Roach A, et al. Donation after circulatory death heart procurement strategy impacts utilization and outcomes of concurrently procured abdominal organs. J Heart Lung Transplant. 2023;42:993–1001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Truog RD, Flescher A, Ladin K. Normothermic regional perfusion—the next frontier in organ transplants? JAMA. 2023;329:2123–2124. [DOI] [PubMed] [Google Scholar]
- 25.Bernat JL, Khush KK, Shemie SD, et al. Knowledge gaps in heart and lung donation after the circulatory determination of death: report of a workshop of the National Heart, Lung, and Blood Institute. J Heart Lung Transplant. 2024;43:1021–1029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Organ Procurement and Transplantation Network (OPTN) Ethics Committee. Ethical Analysis of Normothermic Regional Perfusion (NRP). Available at https://optn.transplant.hrsa.gov/media/unfj5nvq/ethical-implications-of-normothermic-regional-perfusion_pcsummer2023.pdf. Accessed November 20, 2023. [Google Scholar]
- 27.Murphy N, Lingard L, Blackstock L, et al. Protocol for a qualitative pilot study to explore ethical issues and stakeholder trust in the use of normothermic regional perfusion in organ donation in Canada. BMJ Open. 2022;12:e067515. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Morrison LJ, Sandroni C, Grunau B, et al. ; International Liaison Committee on Resuscitation. Organ donation after out-of-hospital cardiac arrest: a scientific statement from the International Liaison Committee on Resuscitation. Circulation. 2023;148:e120–e146. [DOI] [PubMed] [Google Scholar]
- 29.Glazier AK, Capron AM. Normothermic regional perfusion and US legal standards for determining death are not aligned. Am J Transplant. 2022;22:1289–1290. [DOI] [PubMed] [Google Scholar]
- 30.Wall AE, Fiedler A, Karp S, et al. Applying the ethical framework for donation after circulatory death to thoracic normothermic regional perfusion procedures. Am J Transplant. 2022;22:1311–1315. [DOI] [PubMed] [Google Scholar]
- 31.Dhanani S, Hornby L, van Beinum A, et al. ; Canadian Critical Care Trials Group. Resumption of cardiac activity after withdrawal of life-sustaining measures. N Engl J Med. 2021;384:345–352. [DOI] [PubMed] [Google Scholar]
- 32.Smith M, Dominguez-Gil B, Greer DM, et al. Organ donation after circulatory death: current status and future potential. Intensive Care Med. 2019;45:310–321. [DOI] [PubMed] [Google Scholar]
- 33.Hessheimer AJ, Coll E, Torres F, et al. Normothermic regional perfusion vs. super-rapid recovery in controlled donation after circulatory death liver transplantation. J Hepatol. 2019;70:658–665. [DOI] [PubMed] [Google Scholar]
- 34.Jochmans I, Hessheimer AJ, Neyrinck AP, et al. ; ESOT Workstream 04 of the TLJ (Transplant Learning Journey) Project. Consensus statement on normothermic regional perfusion in donation after circulatory death: report from the European Society for Organ Transplantation’s Transplant Learning Journey. Transpl Int. 2021;34:2019–2030. [DOI] [PubMed] [Google Scholar]
- 35.Holm AM, Courtwright A, Olland A, et al. ISHLT position paper on thoracic organ transplantation in controlled donation after circulatory determination of death (cDCD). J Heart Lung Transplant. 2022;41:671–677. [DOI] [PubMed] [Google Scholar]
- 36.Basmaji J, Weijer C, Skaro A, et al. Paving the road for the adoption of normothermic regional perfusion in Canada. Crit Care Explor. 2021;3:e0553. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8:19–32. [Google Scholar]
- 38.Levac D, Colquhoun H, O’Brien KK. Scoping studies: advancing the methodology. Implement Sci. 2010;5:69. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Magliocca JF, Magee JC, Rowe SA, et al. Extracorporeal support for organ donation after cardiac death effectively expands the donor pool. J Trauma. 2005;58:1095–101; discussion 1101.. [DOI] [PubMed] [Google Scholar]
- 40.Robertson JA. The dead donor rule. Hastings Cent Rep. 1999;29:6–14. [PubMed] [Google Scholar]
- 41.Marquis D. Are DCD donors dead? Hastings Cent Rep. 2010;40:24–31. [DOI] [PubMed] [Google Scholar]
- 42.Murphy N, Weijer C, Smith M, et al. Controlled donation after circulatory determination of death: a scoping review of ethical issues, key concepts, and arguments. J Law Med Ethics. 2021;49:418–440. [DOI] [PubMed] [Google Scholar]
- 43.Rodríguez-Arias D, Smith MJ, Lazar NM. Donation after circulatory death: burying the dead donor rule. Am J Bioeth. 2011;11:36–43. [DOI] [PubMed] [Google Scholar]
- 44.Bernat JL. On noncongruence between the concept and determination of death. Hastings Cent Rep. 2013;43:25–33. [DOI] [PubMed] [Google Scholar]
- 45.Joffe AR, Carcillo J, Anton N, et al. Donation after cardiocirculatory death: a call for a moratorium pending full public disclosure and fully informed consent. Philos Ethics Humanit Med. 2011;6:17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Bernat JL, D’Alessandro AM, Port FK, et al. Report of a national conference on donation after cardiac death. Am J Transplant. 2006;6:281–291. [DOI] [PubMed] [Google Scholar]
- 47.Shemie SD, Wilson LC, Hornby L, et al. A brain-based definition of death and criteria for its determination after arrest of circulation or neurologic function in Canada: a 2023 clinical practice guideline. Can J Anaesth. 2023;70:483–557. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.American College of Physicians Statement of Concern. American College of Physicians Web site. Available at https://www.acponline.org/sites/default/files/documents/clinical_information/resources/end_of_life_care/ethics_determination_of_death_and_organ_transplantation_in_nrp_2021.pdf. Accessed August 23, 2023. [Google Scholar]
- 49.Parent B, Moazami N, Wall S, et al. Ethical and logistical concerns for establishing NRP-cDCD heart transplantation in the United States. Am J Transplant. 2020;20:1508–1512. [DOI] [PubMed] [Google Scholar]
- 50.Parent B, Caplan A, Moazami N, et al. Response to American College of Physician’s statement on the ethics of transplant after normothermic regional perfusion. Am J Transplant. 2022;22:1307–1310. [DOI] [PubMed] [Google Scholar]
- 51.DeCamp M, Fins JJ, Snyder Sulmasy L. Rebuttal from Dr DeCamp et al. Chest. 2022;162:292–293. [DOI] [PubMed] [Google Scholar]
- 52.DeCamp M, Snyder Sulmasy L, Fins JJ. POINT: does normothermic regional perfusion violate the ethical principles underlying organ procurement? Yes. Chest. 2022;162:288–290. [DOI] [PubMed] [Google Scholar]
- 53.James L, Parent B, Moazami N, et al. COUNTERPOINT: does normothermic regional perfusion violate the ethical principles underlying organ procurement? No. Chest. 2022;162:290–292. [DOI] [PubMed] [Google Scholar]
- 54.Adams BL, Brenner L, Levan M, et al. cDCDD-NRP is consistent with US legal standards for determining death. Am J Transplant. 2022;22:2302–2305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Nielsen Busch EJ, Mjaaland MT. Does controlled donation after circulatory death violate the dead donor rule? Am J Bioeth. 2023;23:4–11. [DOI] [PubMed] [Google Scholar]
- 56.Wall A, Testa G. Defining the cause of death and vitality of organs in the ethical analysis of controlled donation after circulatory death procedures. Am J Bioeth. 2023;23:35–38. [DOI] [PubMed] [Google Scholar]
- 57.Opole IO, Deep NN, Snyder Sulmasy L. On the ethics of NRP and the American College of Physicians NRP statement. Am J Transplant. 2022;22:1725–1726. [DOI] [PubMed] [Google Scholar]
- 58.Bernat JL, Domínguez-Gil B, Glazier AK, et al. Understanding the brain-based determination of death when organ recovery is performed with DCDD in situ normothermic regional perfusion. Transplantation. 2023;107:1650–1654. [DOI] [PubMed] [Google Scholar]
- 59.McGee A, Gardiner D, Murphy P. Determination of death in donation after circulatory death: an ethical propriety. Curr Opin Organ Transplant. 2018;23:114–119. [DOI] [PubMed] [Google Scholar]
- 60.Gardiner D, McGee A. Death, permanence and current practice in donation after circulatory death. QJM. 2017;110:199–201. [DOI] [PubMed] [Google Scholar]
- 61.Manara A, Large S, Antonini VM, et al. Normothermic regional perfusion is anything but euthanasia. J Cardiothorac Vasc Anesth. 2024;38:1601–1602. [DOI] [PubMed] [Google Scholar]
- 62.Rubin J. The irreversible cannot be reversed: normothermic regional perfusion is euthanasia. J Cardiothorac Vasc Anesth. 2024;38:608–609. [DOI] [PubMed] [Google Scholar]
- 63.Ely EW. Clamping cerebral circulation—breach of the dead donor rule? Am J Transplant. 2022;22:1724–1724. [DOI] [PubMed] [Google Scholar]
- 64.Courtwright AM. Normothermic regional perfusion, causes, and the dead donor rule transplantation. Am J Bioeth. 2023;23:46–47. [DOI] [PubMed] [Google Scholar]
- 65.Peled H, Mathews S, Rhodes D, et al. Normothermic regional perfusion requires careful ethical analysis before adoption into donation after circulatory determination of death. Crit Care Med. 2022;50:1644–1648. [DOI] [PubMed] [Google Scholar]
- 66.Dalle Ave AL, Shaw DM, Bernat JL. Ethical issues in the use of extracorporeal membrane oxygenation in controlled donation after circulatory determination of death. Am J Transplant. 2016;16:2293–2299. [DOI] [PubMed] [Google Scholar]
- 67.Schou A, Mølgaard J, Andersen LW, et al. Ethics in extracorporeal life support: a narrative review. Crit Care. 2021;25:256. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Omelianchuk A. Protecting life and ensuring death-confounding the dead donor rule. Am J Bioeth. 2023;23:20–22. [DOI] [PubMed] [Google Scholar]
- 69.Lazaridis C. Permanent cerebral circulatory arrest is necessary and sufficient for normothermic regional perfusion. Crit Care Med. 2023;51:e95–e96. [DOI] [PubMed] [Google Scholar]
- 70.Murphy NB, Shemie SD, Capron A, et al. Advancing the scientific basis for determining death in controlled organ donation after circulatory determination of death. Transplantation. 2024-108:2197–2208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Manara AR, Murphy PG, O’Callaghan G. Donation after circulatory death. Br J Anaesth. 2012;108(Suppl 1):i108–i121. [DOI] [PubMed] [Google Scholar]
- 72.Dalle Ave AL. Determination of death: from irreversibility to assumability. Am J Transplant. 2022;22:1727–1728. [DOI] [PubMed] [Google Scholar]
- 73.Royo-Villanova M, Miñambres E, Sánchez JM, et al. Maintaining the permanence principle of death during normothermic regional perfusion in controlled donation after the circulatory determination of death: results of a prospective clinical study. Am J Transplant. 2024;24:213–221. [DOI] [PubMed] [Google Scholar]
- 74.Frontera JA, Lewis A, James L, et al. Thoracoabdominal normothermic regional perfusion in donation after circulatory death does not restore brain blood flow. J Heart Lung Transplant. 2023;42:1161–1165. [DOI] [PubMed] [Google Scholar]
- 75.Thiessen C, Gordon EJ, Kelly B, et al. The ethics of donation after circulatory death organ recovery: an overview of new considerations arising from procurement practice and policy changes. Curr Opin Organ Transplant. 2023;28:133–138. [DOI] [PubMed] [Google Scholar]
- 76.Simon JR, Schears RM, Padela AI. Donation after cardiac death and the emergency department: ethical issues. Acad Emerg Med. 2014;21:79–86. [DOI] [PubMed] [Google Scholar]
- 77.Plourde G, Briard JN, Shemie SD, et al. Flow is not perfusion, and perfusion is not function: ancillary testing for the diagnosis of brain death. Can J Anaesth. 2021;68:953–961. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Slessarev M, Gofton T, Shemie SD. Ensuring the permanent cessation of brain function during normothermic regional perfusion. Transplantation. 2022;106:1726–1727. [DOI] [PubMed] [Google Scholar]
- 79.Ríos A, Balaguer A. Social and ethical-moral considerations in cardiopulmonary death donation. Transplant Rep. 2023;8:100126. [Google Scholar]
- 80.Rady MY, Verheijde JL. Ethically increasing the supply of transplantable organs. Ann Intern Med. 2007;146:537. [DOI] [PubMed] [Google Scholar]
- 81.Fox RC. An ignoble form of cannibalism: reflections on the Pittsburgh protocol for procuring organs from non-heart-beating cadavers. Kennedy Inst Ethics J. 1993;3:231–239. [DOI] [PubMed] [Google Scholar]
- 82.Bernat JL, Capron AM, Bleck TP, et al. The circulatory-respiratory determination of death in organ donation. Crit Care Med. 2010;38:963–970. [DOI] [PubMed] [Google Scholar]
- 83.Müller T, Brodie D, Lorusso R, et al. Expanding controlled donation after the circulatory determination of death: stronger emphasis on different cultural, religious and legal backgrounds is needed. Intensive Care Med. 2021;47:724–725. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Smith D, Moazami N. Commentary: normothermic regional perfusion: ethical issues in thoracic organ donation: an important discussion, but stop the press! J Thorac Cardiovasc Surg. 2022;164:155–156. [DOI] [PubMed] [Google Scholar]
- 85.Shapey IM, Summers A, Augustine T, et al. Systematic review to assess the possibility of return of cerebral and cardiac activity after normothermic regional perfusion for donors after circulatory death. Br J Surg. 2019;106:174–180. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Parent B, Caplan A, Moazami N, et al. Regarding normothermic regional perfusion: arguing by insistence is not a strong argument. Am J Transplant. 2022;22:1729–1730. [DOI] [PubMed] [Google Scholar]
- 87.Entwistle JW, Drake DH, Fenton KN, et al. ; Cardiothoracic Ethics Forum. Normothermic regional perfusion: ethical issues in thoracic organ donation. Ann Thorac Surg. 2022;114:44–51. [DOI] [PubMed] [Google Scholar]
- 88.Overby KJ, Weinstein MS, Fiester A. Addressing consent issues in donation after circulatory determination of death. Am J Bioeth. 2015;15:3–9. [DOI] [PubMed] [Google Scholar]
- 89.Ball IM, Honarmand K, Parsons-Leigh J, et al. Heart recovery after circulatory determination of death: time for public engagement. Can J Anaesth. 2019;66:1147–1150. [DOI] [PubMed] [Google Scholar]
- 90.Shah AS. Normothermic regional perfusion in donor heart recovery: establishing a new normal. J Thorac Cardiovasc Surg. 2022;164:142–146. [DOI] [PubMed] [Google Scholar]
- 91.Honarmand K, Ball I, Weiss M, et al. Cardiac donation after circulatory determination of death: protocol for a mixed-methods study of healthcare provider and public perceptions in Canada. BMJ Open. 2020;10:e033932. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Hessheimer AJ, Billault C, Barrou B, et al. Hypothermic or normothermic abdominal regional perfusion in high-risk donors with extended warm ischemia times: impact on outcomes? Transpl Int. 2015;28:700–707. [DOI] [PubMed] [Google Scholar]
- 93.Murphy NB, Hartwick M, Wilson LC, et al. Rationale for revisions to the definition of death and criteria for its determination in Canada. Can J Anaesth. 2023;70:558–569. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Bernat JL. The boundaries of organ donation after circulatory death. N Engl J Med. 2008;359:669–671. [DOI] [PubMed] [Google Scholar]
- 95.Bernat JL. Conceptual issues in DCDD Donor Death Determination. Hastings Cent Rep. 2018;48(Suppl 4):S26–S28. [DOI] [PubMed] [Google Scholar]
- 96.Morley G, Ives J, Bradbury-Jones C, et al. What is ‘moral distress’? A narrative synthesis of the literature. Nurs Ethics. 2019;26:646–662. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Dejohn C, Zwischenberger JB. Ethical implications of extracorporeal interval support for organ retrieval (EISOR). ASAIO J. 2006;52:119–122. [DOI] [PubMed] [Google Scholar]
- 98.Honarmand K, Parsons Leigh J, Basmaji J, et al. Attitudes of healthcare providers towards cardiac donation after circulatory determination of death: a Canadian nation-wide survey. Can J Anaesth. 2020;67:301–312. [DOI] [PubMed] [Google Scholar]
- 99.Egan TM, Requard JJ, 3rd. Ethics of normothermic regional perfusion for donors and definition of death. Chest. 2023;163:e248–e249. [DOI] [PubMed] [Google Scholar]
- 100.Pasrija C, Tipograf Y, Shah AS, et al. Normothermic regional perfusion for donation after circulatory death donors. Curr Opin Organ Transplant. 2023;28:71–75. [DOI] [PubMed] [Google Scholar]
- 101.Lazaridis C. Normothermic regional perfusion: ethically not merely permissible but recommended. Am J Transplant. 2022;22:2285–2286. [DOI] [PubMed] [Google Scholar]


